These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17036907)

  • 21. Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.
    Gallwitz B; Dagogo-Jack S; Thieu V; Garcia-Perez LE; Pavo I; Yu M; Robertson KE; Zhang N; Giorgino F
    Diabetes Obes Metab; 2018 Feb; 20(2):409-418. PubMed ID: 28817231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.
    Gross JL; Kramer CK; Leitão CB; Hawkins N; Viana LV; Schaan BD; Pinto LC; Rodrigues TC; Azevedo MJ;
    Ann Intern Med; 2011 May; 154(10):672-9. PubMed ID: 21576535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes.
    Vilsbøll T; Zdravkovic M; Le-Thi T; Krarup T; Schmitz O; Courrèges JP; Verhoeven R; Bugánová I; Madsbad S
    Diabetes Care; 2007 Jun; 30(6):1608-10. PubMed ID: 17372153
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.
    Rodriguez-Gutierrez R; Lipska KJ; McCoy RG
    JAMA Intern Med; 2016 Mar; 176(3):300-1. PubMed ID: 26882223
    [No Abstract]   [Full Text] [Related]  

  • 26. Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme.
    Zinman B; Schmidt WE; Moses A; Lund N; Gough S
    Diabetes Obes Metab; 2012 Jan; 14(1):77-82. PubMed ID: 21883806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoglycaemia: an overview.
    Graveling AJ; Frier BM
    Prim Care Diabetes; 2009 Aug; 3(3):131-9. PubMed ID: 19782016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Vanderheiden A; Harrison L; Warshauer J; Li X; Adams-Huet B; Lingvay I
    JAMA Intern Med; 2016 Jul; 176(7):939-47. PubMed ID: 27273731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premixed insulin regimens for type 2 diabetes.
    Tsapas A; Karagiannis T; Bekiari E
    Endocrine; 2016 Mar; 51(3):387-9. PubMed ID: 26649859
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor.
    Riddle MC
    Diabetes Care; 2008 Feb; 31 Suppl 2():S125-30. PubMed ID: 18227472
    [No Abstract]   [Full Text] [Related]  

  • 31. Treating type 2 diabetes: incretin mimetics and enhancers.
    Janosz KE; Zalesin KC; Miller WM; McCullough PA
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):387-95. PubMed ID: 19808944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia.
    Davies MJ; Derezinski T; Pedersen CB; Clauson P
    Diabetes Technol Ther; 2008 Aug; 10(4):273-7. PubMed ID: 18715200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizide.
    Seck TL; Engel SS; Williams-Herman DE; Sisk CM; Golm GT; Wang H; Kaufman KD; Goldstein BJ
    Diabetes Res Clin Pract; 2011 Jul; 93(1):e15-7. PubMed ID: 21477878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [How to minimize weight gain associated with insulin treatment].
    Philippe J
    Rev Med Suisse; 2010 Jun; 6(252):1199-200, 1202-4. PubMed ID: 20614755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Summaries for patients. Exenatide or insulin glargine for suboptimally controlled diabetes?
    Ann Intern Med; 2005 Oct; 143(8):I30. PubMed ID: 16230718
    [No Abstract]   [Full Text] [Related]  

  • 36. GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents.
    Trujillo JM; Nuffer W
    Pharmacotherapy; 2014 Nov; 34(11):1174-86. PubMed ID: 25382096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-year efficacy of complex insulin regimens in type 2 diabetes.
    Holman RR; Farmer AJ; Davies MJ; Levy JC; Darbyshire JL; Keenan JF; Paul SK;
    N Engl J Med; 2009 Oct; 361(18):1736-47. PubMed ID: 19850703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Increased risk of hypoglycemia in the elderly and frail. Steep decrease of HbA1c is not always advisable].
    Pampel SL
    MMW Fortschr Med; 2011 Jul; 153(29-31):20. PubMed ID: 21830731
    [No Abstract]   [Full Text] [Related]  

  • 39. Can alpha-glucosidase inhibitors reduce the insulin dosage administered to patients with non-insulin-dependent diabetes mellitus?
    Okada S; Ishii K; Hamada H; Tanokuchi S; Ichiki K; Ota Z
    J Int Med Res; 1995; 23(6):487-91. PubMed ID: 8746617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing postprandial glucose levels in patients with diabetes.
    Tenzer-Iglesias P; Brunton S
    J Fam Pract; 2008 Jan; 57(1 Suppl Managing):S17-24. PubMed ID: 18662529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.